Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small-cell lung cancer: A competing risks analysis

Journal of Clinical Oncology

Volumn 35, Issue 3, 2017, Pages 281-290

  Eguchi, Takashi ^a,b   Bains, Sarina ^a   Lee, Ming Ching ^a,c   Tan, Kay See ^a   Hristov, Boris ^a   Buitrago, Daniel H ^a   Bains, Manjit S ^a   Downey, Robert J ^a   Huang, James ^a   Isbell, James M ^a   Park, Bernard J ^a   Rusch, Valerie W ^a   Jones, David R ^a   Adusumilli, Prasad S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b SHINSHU UNIVERSITY   (Japan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; CLINICAL OUTCOME; FEMALE; FORCED EXPIRATORY VOLUME; GROUPS BY AGE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG LOBECTOMY; LUNG RESECTION; LUNG SUBLOBAR RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY RISK; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNIVARIATE ANALYSIS; ADVERSE EFFECTS; AGE; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; COMPARATIVE STUDY; CONVALESCENCE; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; LUNG; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; NEW YORK; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; PULMONARY DIFFUSING CAPACITY; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85010075853     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.69.0834     Document Type: Article

References (46)

1. Stat Bite Percentage of New Cases by Age Group For Lung and Bronchus Cancer (2008-2012). JNCI J Natl Cancer Inst 108:djw056, 2016
2. Janssen-Heijnen ML, Houterman S, Lemmens VE, et al: Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach. Crit Rev Oncol Hematol 55:231-240, 2005
3. Carmona R, Zakeri K, Green G, et al: Improved method to stratify elderly patients with cancer at risk for competing events. J Clin Oncol 34:1270-1277, 2016
4. NCCN clinical practice guidelines in oncology (NCCN Guidelines): Non-small cell lung cancer version 2.2016. Ft Washington, PA, National Comprehensive Cancer Network, 2016
5. Aberle DR, Adams AM, Berg CD, et al: Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365:395-409, 2011
6. Black WC, Gareen IF, Soneji SS, et al: Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 371:1793-1802, 2014
7. Rocco G, Allen MS, Altorki NK, et al: Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg 96:357-360, 2013
8. Goldstraw P, Chansky K, Crowley J, et al: The IASLC Lung Cancer Staging Project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 11:39-51, 2016
9. Sekine Y, Behnia M, Fujisawa T: Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. Lung Cancer 37:95-101, 2002
10. Kawai H, Tada A, Kawahara M, et al: Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer - A multicenter study. Lung Cancer 49:63-70, 2005
11. Brunelli A, Refai MA, Salati M, et al: Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: Evidence for systematic measurement before lung resection. Eur J Cardiothorac Surg 29:567-570, 2006
12. Sekine Y, Yamada Y, Chiyo M, et al: Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg 84:946-950, 2007
13. Ferguson MK, Vigneswaran WT: Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 85:1158-1164, 2008; discussion 1164-1165
14. Ferguson MK, Gaissert HA, Grab JD, et al: Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: The predictive role of diffusing capacity. J Thorac Cardiovasc Surg 138:1297-1302, 2009
15. Kozower BD, Sheng S, O'Brien SM, et al: STS database risk models: Predictors of mortality and major morbidity for lung cancer resection. Ann Thorac Surg 90:875-881, 2010; discussion 881-883
16. Kondo R, Yoshida K, Eguchi T, et al: Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: A retrospective analysis of Japanese surgical cases. Eur J Cardiothorac Surg 40:1439-1443, 2011
17. Powell HA, Tata LJ, Baldwin DR, et al: Early mortality after surgical resection for lung cancer: An analysis of the English National Lung Cancer Audit. Thorax 68:826-834, 2013
18. Ferguson MK, Watson S, Johnson E, et al: Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg 45:660-664, 2014
19. Zhai R, Yu X, Shafer A, et al: The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. Chest 145:346-353, 2014
20. Berry MF, Jeffrey Yang CF, Hartwig MG, et al: Impact of pulmonary function measurements on long-term survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 100:271-276, 2015
21. Rivera C, Falcoz PE, Bernard A, et al: Surgical management and outcomes of elderly patients with early stage non-small cell lung cancer: A nested case-control study. Chest 140:874-880, 2011
22. Billmeier SE, Ayanian JZ, He Y, et al: Predictors of nursing home admission, severe functional impairment, or death one year after surgery for non-small cell lung cancer. Ann Surg 257:555-563, 2013
23. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
24. Blasberg JD, Pass HI, Donington JS: Sublobar resection: A movement from the Lung Cancer Study Group. J Thorac Oncol 5:1583-1593, 2010
25. Sihoe AD, Van Schil P: Non-small cell lung cancer: When to offer sublobar resection. Lung Cancer 86:115-120, 2014
26. National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. Washington, DC, US Department of Health and Human Services, 2010
27. Hastie TJ: Generalized additive models, in Chambers JM, Hastie TJ (eds): Statistical Models in S. Boca Raton, FL, Chapman and Hall/CRC, 1991, pp 249-287
28. Brunelli A, Kim AW, Berger KI, et al: Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e166S-1690S, 2013 (suppl 5)
29. Fine JP: Regression modeling of competing crude failure probabilities. Biostatistics 2:85-97, 2001
30. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
31. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982
32. Harrell FE Jr: Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY, Springer, 2001
33. Wolbers M, Blanche P, Koller MT, et al: Concordance for prognostic models with competing risks. Biostatistics 15:526-539, 2014
34. Morrison NJ, Abboud RT, Ramadan F, et al: Comparison of single breath carbon monoxide diffusing capacity and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 139:1179-1187, 1989
35. Watters LC, King TE, Schwarz MI, et al: A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 133:97-103, 1986
36. Steenhuis LH, Groen HJ, Koëter GH, et al: Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 16:276-281, 2000
37. Agostoni P, Bussotti M, Cattadori G, et al: Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J 27:2538-2543, 2006
38. Barnett SA, Rusch VW, Zheng J, et al: Contemporary results of surgical resection of non-small cell lung cancer after induction therapy: A review of 549 consecutive cases. J Thorac Oncol 6:1530-1536, 2011
39. Ferguson MK, Saha-Chaudhuri P, Mitchell JD, et al: Prediction of major cardiovascular events after lung resection using a modified scoring system. Ann Thorac Surg 97:1135-1140, 2014
40. Lüchtenborg M, Jakobsen E, Krasnik M, et al: The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer 48:3386-3395, 2012
41. Birim O, Kappetein AP, Waleboer M, et al: Long-term survival after non-small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode. J Thorac Cardiovasc Surg 132:491-498, 2006
42. Rueth NM, Parsons HM, Habermann EB, et al: Surgical treatment of lung cancer: Predicting postoperative morbidity in the elderly population. J Thorac Cardiovasc Surg 143:1314-1323, 2012
43. Ginsberg RJ, Rubinstein LV; Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60:615-622, 1995; discussion 622-623
44. Nitadori J, Bograd AJ, Kadota K, et al: Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst 105:1212-1220, 2013
45. Kadota K, Nitadori JI, Sima CS, et al: Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences following limited resection for small stage I lung adenocarcinomas. J Thorac Oncol, 10:806-814, 2015
46. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al: Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg 113:691-698, 1997; discussion 698-700